Reports for SUN PHARMA CANADA INC
Company Name
SUN PHARMA CANADA INC
Shortage reports
Actual shortage:
35 (8%)
Anticipated shortage:
1 (0%)
Avoided shortage:
6 (1%)
Resolved:
380 (90%)
422
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
37 (100%)
Reversed:
0 (0%)
37
260 (57%)
26 (72%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-08-16 | 2025-02-10 | 202116 |
| TARO-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-08-16 | 2025-02-10 | 202119 |
| TARO-CANDESARTAN | 4MG | TABLET | Resolved | 2022-08-25 | 2023-10-25 | 167923 |
| TARO-CANDESARTAN | 4MG | TABLET | Actual shortage | 2024-09-11 | 2025-01-28 | 237290 |
| TARO-CANDESARTAN | 8MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132929 |
| TARO-CANDESARTAN | 8MG | TABLET | Resolved | 2022-08-25 | 2022-11-03 | 167926 |
| TARO-CANDESARTAN | 8MG | TABLET | Actual shortage | 2023-11-02 | 2025-01-28 | 208955 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2021-01-31 | 2021-02-14 | 132926 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2022-08-25 | 2022-11-03 | 167929 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-01 | 2023-09-25 | 183064 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2023-11-02 | 2024-01-05 | 208958 |
| TARO-CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-10-16 | 2025-01-28 | 240421 |
| TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2022-08-25 | 2023-09-26 | 167932 |
| TARO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-09-11 | 2025-01-28 | 237293 |
| TARO-CEFPROZIL | 250MG | TABLET | Resolved | 2022-11-16 | 2023-02-01 | 175062 |
| TARO-CEFPROZIL | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-09-16 | 2024-02-14 | 169495 |
| TARO-CEFPROZIL | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-09-16 | 2024-02-14 | 169498 |
| TARO-CEFPROZIL | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-09-16 | 2024-02-14 | 169484 |
| TARO-CEFPROZIL | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-09-16 | 2024-02-14 | 169487 |
| TARO-CEFPROZIL | 125MG | POWDER FOR SUSPENSION | Resolved | 2023-11-02 | 2024-01-05 | 208961 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115038 |
| RAN-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115052 |
| RAN-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115046 |
| RAN-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115049 |
| RAN-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-02-02 | 2020-02-02 | 105091 |
| RAN-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115059 |
| RAN-DONEPEZIL | 5MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80060 |
| RAN-DONEPEZIL | 10MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80063 |
| RAN-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91266 |
| RAN-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91269 |
| RAN-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91261 |
| RAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
| RAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| RAN-LISINOPRIL | 5MG | TABLET | Discontinued | 2020-05-27 | 2020-05-27 | 115803 |
| RAN-LISINOPRIL | 10MG | TABLET | Discontinued | 2020-05-27 | 2020-05-27 | 115806 |
| RAN-LISINOPRIL | 5MG | TABLET | Discontinued | 2021-12-07 | 2021-12-07 | 150671 |
| RAN-LISINOPRIL | 20MG | TABLET | Discontinued | 2021-12-07 | 2021-12-07 | 150674 |
| RAN-PANTOPRAZOLE | Discontinued | 2019-03-29 | 2019-03-29 | 80057 | ||
| RAN-PREGABALIN | 225MG | CAPSULE | Discontinued | 2019-10-04 | 2019-10-04 | 95487 |
| RAN-PREGABALIN | 300MG | CAPSULE | Discontinued | 2020-05-27 | 2020-05-27 | 115811 |